GPCRStructure Therapeutics Inc.

HealthcareUSD
$49.42

The financials

Structure Therapeutics Inc. by the numbers

Structure Therapeutics Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$119M−$70Mn/a
Net income−$106M−$62Mn/a
Diluted EPS−$0.49−$0.36n/a

Biotechnology

Ranks #83 of 145 by Smart Score

Compare peers
DYN+1.4%
Dyne Therapeutics, Inc.
QURE+0.51%
uniQure N.V.
BEAM+0.09%
Beam Therapeutics Inc.
IDYA+0.03%
IDEAYA Biosciences, Inc.
ELVN+2.8%
Enliven Therapeutics, Inc.
ARQT-2.5%
Arcutis Biotherapeutics, Inc.